Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: Findings from 14-713 patients in the Swedish Heart Failure Registry

European Journal of Heart Failure

Volumn 16, Issue 10, 2014, Pages 1073-1081

  Lund, Lars H ^a,b   Benson, Lina ^a   Ståhlberg, Marcus ^a,b   Braunschweig, Frieder ^a,b   Edner, Magnus ^a,b   Dahlström, Ulf ^c   Linde, Cecilia ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Age; Cardiac resynchronization therapy; Epidemiology; Heart Failure; Intraventricular conduction delay; Left bundle branch block; QRS width

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; ECG ABNORMALITY; FEMALE; FOLLOW UP; GROUPS BY AGE; HAZARD RATIO; HEALTH CARE UTILIZATION; HEART EJECTION FRACTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART VENTRICLE CONDUCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; MORTALITY; PROGNOSIS; QRS COMPLEX; QRS PROLONGATION; REGISTER; SURVIVAL; ARRHYTHMIAS, CARDIAC; BUNDLE-BRANCH BLOCK; COMPLICATION; CONGENITAL MALFORMATION; ELECTROCARDIOGRAPHY; HEART FAILURE; HEART MUSCLE CONDUCTION SYSTEM; MIDDLE AGED; PREVALENCE; PROCEDURES; SWEDEN; TREATMENT OUTCOME; UTILIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; BUNDLE-BRANCH BLOCK; CARDIAC RESYNCHRONIZATION THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; REGISTRIES; SWEDEN; TREATMENT OUTCOME;

EID: 84907972326     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.162     Document Type: Article

References (24)

1. Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Claude Daubert J, Sherfesee L, Wells GA, Tang AS,. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J 2013; 34: 3547-3556.
2. Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA,. Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med 2011; 154: 401-412.
3. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE, Guidelines ESCCfP, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document R, Kirchhof P, Blomstrom-Lundqvist C, Badano LP, Aliyev F, Bansch D, Baumgartner H, Bsata W, Buser P, Charron P, Daubert JC, Dobreanu D, Faerestrand S, Hasdai D, Hoes AW, Le Heuzey JY, Mavrakis H, McDonagh T, Merino JL, Nawar MM, Nielsen JC, Pieske B, Poposka L, Ruschitzka F, Tendera M, Van Gelder IC, Wilson CM., 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013; 34: 2281-2329.
4. Van Spall HG, Toren A, Kiss A, Fowler RA,. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. J Am Med Assoc 2007 Mar 21; 297: 1233-1240.
5. Lund LH, Mancini D,. Heart failure in women. Med Clin N Am 2004 Sep; 88: 1321-1345, xii.
6. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J,. The European cardiac resynchronization therapy survey. Eur Heart J 2009; 30: 2450-2460.
7. Zabarovskaja S, Gadler F, Braunschweig F, Stahlberg M, Hornsten J, Linde C, Lund LH,. Women have better long-term prognosis than men after cardiac resynchronization therapy. Europace 2012; 14: 1148-1155.
8. Bogale N, Priori S, Cleland JG, Brugada J, Linde C, Auricchio A, van Veldhuisen DJ, Limbourg T, Gitt A, Gras D, Stellbrink C, Gasparini M, Metra M, Derumeaux G, Gadler F, Buga L, Dickstein K,. The European CRT Survey: 1 year (9-15 months) follow-up results. EurJ Heart Fail 2012; 14: 61-73.
9. Brambatti M, Guerra F, Matassini MV, Cipolletta L, Barbarossa A, Urbinati A, Marchesini M, Capucci A,. Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age. Europace 2013; 15: 704-710.
10. Killu AM, Wu JH, Friedman PA, Shen WK, Webster TL, Brooke KL, Hodge DO, Wiste HJ, Cha YM,. Outcomes of cardiac resynchronization therapy in the elderly. Pacing Clin Electrophysiol 2013; 36: 664-672.
11. Verbrugge FH, Dupont M, De Vusser P, Rivero-Ayerza M, Van Herendael H, Vercammen J, Jacobs L, Verhaert D, Vandervoort P, Tang WH, Mullens W,. Response to cardiac resynchronization therapy in elderly patients (≥-70-years) and octogenarians. Eur J Heart Fail 2013; 15: 203-210.
12. Eriksson P, Hansson PO, Eriksson H, Dellborg M,. Bundle-branch block in a general male population: the study of men born 1913. Circulation 1998; 98: 2494-2500.
13. Lund LH, Jurga J, Edner M, Benson L, Dahlstrom U, Linde C, Alehagen U,. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. Eur Heart J 2013; 34: 529-539.
14. Zareba W, Klein H, Cygankiewicz I, Hall WJ, McNitt S, Brown M, Cannom D, Daubert JP, Eldar M, Gold MR, Goldberger JJ, Goldenberg I, Lichstein E, Pitschner H, Rashtian M, Solomon S, Viskin S, Wang P, Moss AJ,. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011; 123: 1061-1072.
15. Gold MR, Thebault C, Linde C, Abraham WT, Gerritse B, Ghio S, St John Sutton M, Daubert JC,. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation 2012; 126: 822-829.
16. van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, Swedberg K,. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009; 11: 1143-1151.
17. Lund LH, Benson L, Dahlstrom U, Edner M,. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction. J Am Med Assoc 2012; 308: 2108-2117.
18. Therneau T,. Grambsch P. In, Dietz K, Gail M, Krickeberg K, Samet J, Tsiatis A, eds. Modeling Survival Data: Extending the Cox Model. New York: Springer-Verlag; 2000.
19. Thorvaldsen T, Benson L, Stahlberg M, Dahlstrom U, Edner M, Lund LH,. Triage of patients with moderate to severe heart failure: who should be referred to a heart failure center? J Am Coll Cardiol 2013; 63: 661-671.
20. Dickstein K,. Cardiac resynchronization therapy in seniors: when are we too old to deserve a device that makes us feel better and improves clinical outcomes? Eur J Heart Fail 2013; 15: 128-129.
21. Aranda JM Jr, Woo GW, Conti JB, Schofield RS, Conti CR, Hill JA,. Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration. Am J Cardiol 2005; 95: 889-891.
22. Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Inge PJ, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW,. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation 2010; 122: 585-596.
23. Fonarow GC, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB,. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). ArchI Intern Med 2007; 167: 1493-1502.
24. Loh JC, Creaser J, Rourke DA, Livingston N, Harrison TK, Vandenbogaart E, Moriguchi J, Hamilton MA, Tseng CH, Fonarow GC, Horwich TB,. Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993 to 2010: findings from a university referral center. Circ Heart Fail 2013; 6: 411-419.